Status:
COMPLETED
Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients
Lead Sponsor:
Centre Hospitalier Henri Duffaut - Avignon
Conditions:
Psoriatic Arthritis
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Psoriatic arthritis is characterized with pain, swelling and joint stiffness. These are inflammatory reactions against tendons, ligaments and joints associated with fatigue. In France, almost 93.000 p...
Eligibility Criteria
Inclusion
- Patient over 18 years old.
- Patient with psoriatic arthritis of any stage or duration, followed in the center's rheumatology or dermatology departments, whether or not treated with systemic therapy.
- Patient with all forms of cuteaneous psoriasis (plaque, inverted, erythrodermic or guttate), whatever the stage or duration of the disease, followed in the center's dermatology department, whether or not treated with systemic therapy.
Exclusion
- Patient with auto-inflammatory joint disease: ankylosing spondylitis, rheumatoid arthritis.
- Patient with auto-immune disease involving skin lesions: lupus, dermatomyositis, morphea, pemphigus, pemphigoid, Sjögren's syndrome.
- Cancer.
- Pregnant women.
- Severe heart failure (New York Heart Association Class III or IV).
- Severe renal failure (DFG \< 30).
- Hepatic failure.
- Anemia \< 10g/dL.
- Patient under legal protection, deprived of liberty or unable to be included in a research protocol.
Key Trial Info
Start Date :
March 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 2 2025
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06101706
Start Date
March 11 2024
End Date
September 2 2025
Last Update
January 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier d'Avignon
Avignon, France